Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eilat Shinar

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Tropical Doctor|October 13, 2006
Accuracy and cost-benefit of pooled versus singleton screening blood donations for anti-HIV: impact on different blood bank set-upsLena Novack, Joseph S Pliskin, Eilat Shinar, et al.
Transfusion|January 28, 2009
Blood donors with positive direct antiglobulin tests are at increased risk for cancerYakir Rottenberg, Vered Yahalom, Eilat Shinar, et al.
Journal of Clinical Microbiology|August 8, 2006
Use of seroconversion panels to estimate delay in detection of anti-human immunodeficiency virus antibodies by enzyme-linked immunosorbent assay of pooled compared to singleton serum samplesLena Novack, Noya Galai, Arieh Yaari, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 7, 2013
Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in IsraelShmuel Stienlauf, Vered Yahalom, Eilat Shinar, et al.
Emerging Infectious Diseases|July 24, 2009
Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, IsraelShmuel Stienlauf, Vered Yahalom, Eli Schwartz, et al.
Vox Sanguinis|March 12, 2019
Attitudes and perceptions among men having sex with men towards a new non-deferral blood donation policy in IsraelItzchak Levy, Liraz Olmer, Yuval Livnat, et al.
Harefuah|March 22, 2021
[COVID-19 - BLOOD GROUPS, ANTIBODIES AND CONVALESCENT PLASMA]Marina Izak, Vered Yahalom, Yasmin Maor, et al.
Emerging Infectious Diseases|April 26, 2024
Cross-Sectional Study of Q Fever Seroprevalence among Blood Donors, Israel, 2021Nesrin Ghanem-Zoubi, Yafit Atiya-Nasagi, Evgeniy Stoyanov, et al.
Transfusion|March 21, 2019
HIV-1/2 screening in blood centers: implementing a two-step serological screening assay approach to reduce donor deferralEvgeniy Stoyanov, Yael Gozlan, Marina Wax, et al.
The American Journal of Gastroenterology|October 19, 2002
The use of a single serological marker underestimates the prevalence of celiac disease in Israel: a study of blood donorsRaanan Shamir, Aaron Lerner, Eilat Shinar, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Tropical Doctor|October 13, 2006
Accuracy and cost-benefit of pooled versus singleton screening blood donations for anti-HIV: impact on different blood bank set-upsLena Novack, Joseph S Pliskin, Eilat Shinar, et al.
Transfusion|January 28, 2009
Blood donors with positive direct antiglobulin tests are at increased risk for cancerYakir Rottenberg, Vered Yahalom, Eilat Shinar, et al.
Journal of Clinical Microbiology|August 8, 2006
Use of seroconversion panels to estimate delay in detection of anti-human immunodeficiency virus antibodies by enzyme-linked immunosorbent assay of pooled compared to singleton serum samplesLena Novack, Noya Galai, Arieh Yaari, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 7, 2013
Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in IsraelShmuel Stienlauf, Vered Yahalom, Eilat Shinar, et al.
Emerging Infectious Diseases|July 24, 2009
Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, IsraelShmuel Stienlauf, Vered Yahalom, Eli Schwartz, et al.
Vox Sanguinis|March 12, 2019
Attitudes and perceptions among men having sex with men towards a new non-deferral blood donation policy in IsraelItzchak Levy, Liraz Olmer, Yuval Livnat, et al.
Harefuah|March 22, 2021
[COVID-19 - BLOOD GROUPS, ANTIBODIES AND CONVALESCENT PLASMA]Marina Izak, Vered Yahalom, Yasmin Maor, et al.
Emerging Infectious Diseases|April 26, 2024
Cross-Sectional Study of Q Fever Seroprevalence among Blood Donors, Israel, 2021Nesrin Ghanem-Zoubi, Yafit Atiya-Nasagi, Evgeniy Stoyanov, et al.
Transfusion|March 21, 2019
HIV-1/2 screening in blood centers: implementing a two-step serological screening assay approach to reduce donor deferralEvgeniy Stoyanov, Yael Gozlan, Marina Wax, et al.
The American Journal of Gastroenterology|October 19, 2002
The use of a single serological marker underestimates the prevalence of celiac disease in Israel: a study of blood donorsRaanan Shamir, Aaron Lerner, Eilat Shinar, et al.
Pageof 7